Technology
Novadip reports promising interim results from its first-in-human proof-of-concept trial with NVDX3, a new game changer in the bone field
(MENAFN Editorial) At six months post-grafting surgery with NVDX3, x-rays demonstrate that 90% of patients have reached, or are steadily progressing towards, complete bone healing ...
By: menafn
- Oct 19 2024
- 0
- 0 Views
ONLY AVAILABLE IN PAID PLANS